Market Intelligence Report 2026 · Working Draft V1 · August 2026

Canada has capacity —not yet resilience.

The 108-page report as live dashboards: capacity, workforce, radiopharmacy and access — every figure carrying its evidence tier and page reference.

Prepared for · 108 pages · CANM · ACMN

Province lens

Canada-wide · all analytics panels follow this lens

Eight figures that frame the market.

Live from the Interactive Map dataset

The map,
charted.

239 current records · counts recompute under the province lens.

Centres by provincecurrent records · lens highlighted
Modality mixverified installs
Manufacturer sharerecords with model data
Isotope footprinttop 10 by records
Procedure categoriestop 10 · records listing the category

03 · Market scale & capacity

Scale is established;
headroom is not.

Not one national market — a set of provincial systems. CADTH 2022–2023 baseline, Tier A·B.

Provincial capacity matrix · report p.29 · verified via pdfplumber against CADTH Tables 1–2

04 · Workforce

The constraint may be the team,
not the scanner.

Technologist headcount versus the four-method estimated need. Physician stock is stable but concentrated.

NMT headcount vs estimated needCAMRT 2024 · weighted blend of methods A–D

05 · Radiopharmacy

An operating chain,
not a product list.

F-18 underpins every isotope-associated facility, yet route depth is less visible. The unit of resilience is the complete route to the patient slot.

Isotope footprintbreadth vs route depth · p.37
Route risk & contingencysingle points of failure · p.38

90-day launch plan

    06 · Access

    Can patients use it
    when they need it?

    The evidence supports a pilot design, not a national access claim — no national wait-time or travel-time dataset exists yet.

    Access scorecard · report p.47

    07 · Value of demand

    Value is when imaging
    changes a pathway.

    Clinical demand mixCADTH · p.62

    +18.2% public exam growth since 2019–20 · shares do not sum to 100%

    Value layersquestion · measure · p.63

    The strategic constraint is effective capacity — the unit of resilience is the complete route to the patient slot.

    Market Intelligence Report 2026 · pp. 5–6

    60CADTH units85PET records113/114service mentions249CANM records59survey sites

    Five counts, one reconciliation — each is correct for its own denominator · p.12

    08 · Strategic risks

    Protect what Canada
    already operates.

    Top risk register · report p.70 · verified via pdfplumber

    09 · Investment case

    Five decisions
    for 2026.

    A minimum investable portfolio judged by capacity released, not visibility. Approve Protect now; use 2027 evidence to Convert; reserve Scale for validated models.

    Portfolio envelope CAD $5.3–13.9M across 2026–2030.

    Protect portfolioapprove now · p.76
    Convert & Scale portfoliogated on 2027 evidence · p.77

    10 · What this means for partners

    Twelve insights
    for industry.

    11 · Evidence & caveats

    A number is not weak
    because it is incomplete.

    Blank means not reported — never zero. Every figure carries its tier; ranges replace false precision.

    A

    Validated public datasets — CADTH, CAMRT, CAPER, Royal College.

    B

    Reconciled CANM master dataset — the map dataset itself.

    C

    2026 CANM survey — 59 retained sites, validation ongoing.

    D

    Modelled estimates — always shown as ranges with assumptions.

    15Flags & contradictions — read before quoting

      Intelligence

      The Market Intelligence Report as live dashboards. A separate tier, reserved for the report's funding partners and CANM governance. Enter the Intelligence access code.

      Need access? Request a code →

      ← Back to the public map